Home › NDC Lookup › RxCUI directory › RxCUI 198443

Acetaminophen 650 MG Rectal Suppository — RxCUI 198443

RxNorm drug concept · Semantic clinical drug
RxCUI 198443 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198443
Official nameAcetaminophen 650 MG Rectal Suppository
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 650 MG Rectal Suppository
FDA products mapped2
Package NDCs mapped5
Reported Medicaid activity (SDUD)6,732 prescriptions · 22 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Acetaminophen Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. The IV form is used when you can't take medication by mouth — for example, after surgery, if you're nauseated, or if you need faster, more reliable absorption. It d...
  • Why am I getting acetaminophen through an IV instead of just taking a pill?
  • Yes, Acetaminophen Injection is approved for children — for pain relief in kids 2 years and older, and for fever reduction in patients of all ages, including premature newborns bor...
  • The most important things to watch for are signs of a serious allergic reaction — swelling of your face, mouth, or throat, trouble breathing, or hives — and any new skin rash. Eith...
📖 Read our full Acetaminophen Injection guide →

🕸️ Concept Web — How Acetaminophen 650 MG Rectal Suppository Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Acetaminophen 650 MG Rectal Suppository RxCUI 198443

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Acetaminophen 161
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Acephen 225064
    • Feverall 217115
  3. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Acetaminophen Rectal Suppository 370508
    • Acetaminophen Rectal Product 1152844
    • Acetaminophen Rectal Suppository [Acephen] 367572
    • Acetaminophen Rectal Suppository [Feverall] 367547
    • Acephen Rectal Product 1168402
    • Feverall Rectal Product 1168297
    • Rectal Suppository 316978
    • Rectal Product 1151127
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Acetaminophen 650 MG 315268
    • Acetaminophen 650 MG Rectal Suppository [Acephen] 209363
    • Acetaminophen 650 MG Rectal Suppository [Feverall] 209364
    • Acetaminophen 650 MG [Acephen] 569974
    • Acetaminophen 650 MG [Feverall] 569975

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Acetaminophen 650 MG SCDC · 315268
  • Acetaminophen Rectal Suppository SCDF · 370508
  • Acetaminophen Rectal Product SCDG · 1152844

Brand-Name Concepts

  • Acetaminophen 650 MG Rectal Suppository [Acephen] SBD · 209363
  • Acetaminophen 650 MG Rectal Suppository [Feverall] SBD · 209364
  • Acetaminophen 650 MG [Acephen] SBDC · 569974
  • Acetaminophen 650 MG [Feverall] SBDC · 569975
  • Acetaminophen Rectal Suppository [Acephen] SBDF · 367572
  • Acetaminophen Rectal Suppository [Feverall] SBDF · 367547
  • Acephen Rectal Product SBDG · 1168402
  • Feverall Rectal Product SBDG · 1168297
  • Acephen BN · 225064
  • Feverall BN · 217115

📦 FDA Products & Package NDCs

2 products · 5 package NDCs
5 package NDCs map to RxCUI 198443 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
45802-0730-00 1 SUPPOSITORY in 1 BLISTER PACK (45802-730-00) acetaminophen pain reliever fever reducer Padagis Israel Pharmaceuticals Ltd 2010-10-28
45802-0730-30 12 BLISTER PACK in 1 CARTON (45802-730-30) / 1 SUPPOSITORY... acetaminophen pain reliever fever reducer Padagis Israel Pharmaceuticals Ltd 2010-10-28
45802-0730-32 50 BLISTER PACK in 1 CARTON (45802-730-32) / 1 SUPPOSITORY... acetaminophen pain reliever fever reducer Padagis Israel Pharmaceuticals Ltd 2010-11-22
45802-0730-33 100 BLISTER PACK in 1 CARTON (45802-730-33) / 1 SUPPOSITORY... acetaminophen pain reliever fever reducer Padagis Israel Pharmaceuticals Ltd 2010-10-28
70677-1271-01 12 BLISTER PACK in 1 CARTON (70677-1271-1) / 1 SUPPOSITORY... foster and thrive pain reliever Strategic Sourcing Services LLC 2025-04-15
Observed labelers: Padagis Israel Pharmaceuticals Ltd (4) · Strategic Sourcing Services LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.3395
Range $0.3395–$0.3395 · middle 50% $0.3395–$0.3395 · 5 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.